Implant Sciences QS-B220 Trace Detection System Gains Further Traction in the European Airport Security Market
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has sold its Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detector to a new customer in Europe. The unit will be used for airport security at a major international airport in Europe.
"Designed to meet the requirements of aviation security professionals, our desktop trace detector is gaining increasing acceptance and traction in global markets. As we continue to grow our distribution channel, we look forward to demonstrating its advantages in increasing numbers of procurements," stated Implant Sciences' President and CEO, Glenn D. Bolduc.
Business Environment and Investment Outlook for ISR Technologies
"The QS-B220 provides an effective method for screening passengers without concerns about radiation and privacy. This and the ability to adapt the easy-to-use touch-screen interface to the local language were important factors in Implant Sciences winning this order from a new customer through a new distributor," added Dr. Darryl Jones, Implant Sciences' Vice President of Sales and Marketing.
Source : Implant Sciences Corp.
Sep 29 - Oct 1, 2014 - Rome, Italy
Sep 8 - 11, 2014 - Huntsville, United States